Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Shares Outstanding (Diluted Average): 2024-2025

Historic Shares Outstanding (Diluted Average) for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $87.6 million.

  • Kura Oncology's Shares Outstanding (Diluted Average) rose 0.80% to $87.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.6 million, marking a year-over-year increase of 0.80%. This contributed to the annual value of $86.2 million for FY2024, which is N/A change from last year.
  • Kura Oncology's Shares Outstanding (Diluted Average) amounted to $87.6 million in Q3 2025, which was up 0.07% from $87.6 million recorded in Q2 2025.
  • Kura Oncology's 5-year Shares Outstanding (Diluted Average) high stood at $87.6 million for Q3 2025, and its period low was $83.9 million during Q1 2024.
  • For the 2-year period, Kura Oncology's Shares Outstanding (Diluted Average) averaged around $86.6 million, with its median value being $87.0 million (2024).
  • Data for Kura Oncology's Shares Outstanding (Diluted Average) shows a peak YoY increased of 4.18% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Kura Oncology's Shares Outstanding (Diluted Average) stood at $86.2 million in 2024, then grew by 0.80% to $87.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $87.6 million in Q3 2025, compared to $87.6 million in Q2 2025 and $87.4 million in Q1 2025.